Kwang-Kyun Park Selected Research

7,12-dimethylbenz(a)anthracene-DNA adduct (DMBA-DNA adduct)

7/2008

Hemin inhibits cyclooxygenase-2 expression through nuclear factor-kappa B activation and ornithine decarboxylase expression in 12-O-tetradecanoylphorbol-13-acetate-treated mouse skin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kwang-Kyun Park Research Topics

Disease

43	Neoplasms (Cancer) 01/2021 - 01/2002
11	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2009
10	Squamous Cell Carcinoma of Head and Neck 01/2021 - 04/2007
10	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2005
7	Bone Resorption 12/2018 - 01/2012
5	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 01/2006
5	Edema (Dropsy) 09/2014 - 08/2002
5	Carcinogenesis 04/2013 - 01/2002
5	Inflammation (Inflammations) 01/2010 - 01/2002
4	Osteolysis 01/2018 - 01/2015
4	Body Weight (Weight, Body) 03/2017 - 01/2005
4	Mouth Neoplasms (Oral Cancer) 02/2017 - 04/2007
4	Colonic Neoplasms (Colon Cancer) 09/2014 - 06/2009
4	Carcinoma (Carcinomatosis) 07/2011 - 01/2010
4	Papilloma (Papillomatosis) 01/2006 - 08/2002
3	Periodontitis 12/2018 - 02/2002
3	Lung Neoplasms (Lung Cancer) 01/2018 - 02/2003
3	Experimental Arthritis 01/2010 - 01/2010
3	Arthritis (Polyarthritis) 01/2010 - 01/2010
2	Postmenopausal Osteoporosis 01/2018 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2017 - 03/2014
2	Osteoporosis 01/2015 - 12/2012
2	Atherosclerosis 03/2014 - 06/2007
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2013 - 05/2009
1	Triple Negative Breast Neoplasms 01/2017
1	Asthma (Bronchial Asthma) 06/2016

Drug/Important Bio-Agent (IBA)

8	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2013 - 08/2002
7	Messenger RNA (mRNA)IBA 01/2018 - 01/2002
7	anthraceneIBA 09/2014 - 01/2002
7	Cisplatin (Platino)FDA LinkGeneric 07/2012 - 05/2004
6	xanthorrhizolIBA 01/2021 - 05/2004
6	NF-kappa B (NF-kB)IBA 02/2010 - 02/2003
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2008
5	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 07/2009
5	isoliquiritigenin (GU 17)IBA 12/2015 - 01/2006
5	SaponinsIBA 01/2015 - 06/2007
5	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 07/2008 - 01/2002
4	CytokinesIBA 12/2018 - 07/2008
4	Parathyroid Hormone-Related ProteinIBA 02/2017 - 02/2014
4	Methanol (Carbinol)IBA 01/2017 - 02/2003
4	RANK LigandIBA 01/2017 - 03/2014
4	Transcription Factors (Transcription Factor)IBA 02/2010 - 08/2002
4	Phorbol EstersIBA 01/2010 - 08/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2006
3	LigandsIBA 01/2017 - 01/2011
3	TriterpenesIBA 01/2015 - 12/2013
3	Transforming Growth Factor beta (TGF-beta)IBA 07/2014 - 05/2009
3	buddlejasaponin IVIBA 12/2013 - 06/2007
3	SesquiterpenesIBA 04/2013 - 01/2005
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2012 - 07/2009
3	EnzymesIBA 01/2010 - 11/2004
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2009 - 08/2002
3	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 06/2008 - 11/2004
3	CarcinogensIBA 04/2007 - 02/2003
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 05/2009
2	artemisinin (artemisinine)IBA 01/2018 - 01/2011
2	ChemokinesIBA 01/2017 - 12/2015
2	OsteoprotegerinIBA 01/2017 - 12/2015
2	lysophosphatidic acidIBA 03/2014 - 01/2012
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 11/2012 - 09/2012
2	ginsenoside Rg3IBA 07/2012 - 02/2003
2	ErbB Receptors (EGF Receptor)IBA 04/2012 - 01/2006
2	Tissue Inhibitor of Metalloproteinase-1IBA 01/2012 - 07/2009
2	kalopanax saponin AIBA 01/2012 - 07/2009
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2012 - 07/2009
2	phorbolIBA 01/2012 - 07/2009
2	decursinIBA 07/2011 - 07/2009
2	Dihydrotachysterol (AT 10)IBA 01/2010 - 01/2010
2	Collagen Type II (Type II Collagen)IBA 01/2010 - 01/2010
2	GinsenosidesIBA 01/2010 - 02/2003
2	FlavonoidsIBA 05/2009 - 01/2006
2	NitrogenIBA 07/2008 - 01/2005
2	AntioxidantsIBA 02/2003 - 02/2003
1	Chemokine CX3CL1IBA 01/2021
1	E2F Transcription FactorsIBA 01/2018
1	Activating Transcription Factor 3IBA 01/2018
1	Nicotine FDA Link 03/2017
1	SmokeIBA 03/2017
1	Biomarkers (Surrogate Marker)IBA 02/2017
1	liensinineIBA 01/2017
1	AntigensIBA 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	nuciferineIBA 01/2017
1	AntibodiesIBA 01/2017
1	Gefitinib (Iressa)FDA Link 01/2015
1	RhamnoseIBA 01/2015
1	platycodin DIBA 01/2015
1	Arabinose (L-Arabinose)IBA 01/2015
1	DisaccharidesIBA 01/2015
1	saikosaponin DIBA 01/2015
1	tert-ButylhydroperoxideIBA 09/2014
1	3- (4,5- dimethyl- 2- thiazolyl)- 2,5- diphenyl- 2H- tetrazolium bromideIBA 09/2014
1	DAPIIBA 09/2014
1	Superoxides (Superoxide)IBA 09/2014

Therapy/Procedure

10	Oral Administration 01/2017 - 07/2009
4	Therapeutics 09/2013 - 05/2004
1	Traditional Medicine (Folk Remedies) 12/2018
1	Drug Therapy (Chemotherapy) 01/2018
1	East Asian Traditional Medicine (Oriental Medicine) 06/2016